摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-(3-trifluoroacetylphenyl)hydrazinecarboxylate | 236386-25-7

中文名称
——
中文别名
——
英文名称
ethyl 2-(3-trifluoroacetylphenyl)hydrazinecarboxylate
英文别名
ethyl N-[3-(2,2,2-trifluoroacetyl)anilino]carbamate
ethyl 2-(3-trifluoroacetylphenyl)hydrazinecarboxylate化学式
CAS
236386-25-7
化学式
C11H11F3N2O3
mdl
——
分子量
276.215
InChiKey
QFDGVKRMPBQKBM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    19.0
  • 可旋转键数:
    4.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    67.43
  • 氢给体数:
    2.0
  • 氢受体数:
    4.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 2-(3-trifluoroacetylphenyl)hydrazinecarboxylate吡啶盐酸羟胺 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以98%的产率得到ethyl 2-(3-trifluoroacetyloximephenyl)hydrazinecarboxylate
    参考文献:
    名称:
    Trifluoromethyldiazirinylphenyldiazenes:  New Hemoprotein Active-Site Probes
    摘要:
    The photoactivatable trifluoromethyldiazirinylphenyldiazene probes 1a and 2a have been synthesized, and their utility in the mapping of hemoprotein active sites has been validated with myoglobin (Mb). Reaction of the probes with Mb yields Fe-aryl adducts. Photolysis of these adducts unmasks a carbene that cross-links to active-site protein residues. Migration of the aryl group from the iron to a porphyrin nitrogen then attaches the porphyrin chromophore to the labeled amino acid residue. Tryptic digestion of the labeled proteins followed by mass spectrometric analysis of the peptides has identified Leu-29, His-64, Ile-107, and Val-68 as active-site residues. Previous studies with an arylnitrene probe, which appears to only react with nucleophilic groups, identified His-64 as an active-site residue [Tschirret-Guth, R. A.; Medzihradszky, K. F.; Ortiz de Montellano, P. R. J. Am. Chem. Sec. 1998, 120, 7404-7410]. These studies have identified all but one of the active-site amino acids in contact with the probe. The present strategy not only labels active-site amino acids but also, because the probe is rigidly held in the active site, provides approximate locations for the labeled residues with respect to the heme iron atom. Validation of the Strategy with myoglobin opens the way to use of the approach with hemoproteins of unknown active-site structure.
    DOI:
    10.1021/ja990351h
  • 作为产物:
    描述:
    1-(3-aminophenyl)-2,2,2-trifluoroethanone吡啶盐酸 、 tin(ll) chloride 、 sodium nitrite 作用下, 以 乙腈 为溶剂, 反应 0.57h, 生成 ethyl 2-(3-trifluoroacetylphenyl)hydrazinecarboxylate
    参考文献:
    名称:
    Trifluoromethyldiazirinylphenyldiazenes:  New Hemoprotein Active-Site Probes
    摘要:
    The photoactivatable trifluoromethyldiazirinylphenyldiazene probes 1a and 2a have been synthesized, and their utility in the mapping of hemoprotein active sites has been validated with myoglobin (Mb). Reaction of the probes with Mb yields Fe-aryl adducts. Photolysis of these adducts unmasks a carbene that cross-links to active-site protein residues. Migration of the aryl group from the iron to a porphyrin nitrogen then attaches the porphyrin chromophore to the labeled amino acid residue. Tryptic digestion of the labeled proteins followed by mass spectrometric analysis of the peptides has identified Leu-29, His-64, Ile-107, and Val-68 as active-site residues. Previous studies with an arylnitrene probe, which appears to only react with nucleophilic groups, identified His-64 as an active-site residue [Tschirret-Guth, R. A.; Medzihradszky, K. F.; Ortiz de Montellano, P. R. J. Am. Chem. Sec. 1998, 120, 7404-7410]. These studies have identified all but one of the active-site amino acids in contact with the probe. The present strategy not only labels active-site amino acids but also, because the probe is rigidly held in the active site, provides approximate locations for the labeled residues with respect to the heme iron atom. Validation of the Strategy with myoglobin opens the way to use of the approach with hemoproteins of unknown active-site structure.
    DOI:
    10.1021/ja990351h
点击查看最新优质反应信息